This is a demo store. No orders will be fulfilled.

Enokizumab (anti-IL-9) - Primary antibody, specific to IL9, >95%, high purity, Human IgG1, INHIBITOR of Interleukin-9 inhibitor, INHIBITOR of Interleukin-9 inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab175530
Grouped product items
SKU Size
Availability
Price Qty
Ab175530-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$49.90
Ab175530-1mg
1mg
5
$239.90
Ab175530-5mg
5mg
1
$619.90
Ab175530-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$999.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Enokizumab (anti-IL-9) - Primary antibody, specific to IL9, >95%, high purity, Human IgG1, INHIBITOR of Interleukin-9 inhibitor
Synonyms Cytokine P40 antibody | Homolog of mouse T cell and mast cell growth factor 40 antibody | HP40 antibody | IL 9 antibody | IL-9 antibody | Il9 antibody | IL9_HUMAN antibody | Interleukin 9 antibody | Interleukin-9 antibody | Mast cell growth factor antibod
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity IL9
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Interleukin-9 inhibitor
Product Description

Enokizumab (anti-IL-9) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 27.5 kDa (Light Chain) & 54.2 kDa (Heavy Chain), under reducing conditions; 179.0 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95%
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 909875-08-7

Associated Targets(Human)

IL9 Tbio Interleukin-9 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Enokizumab (anti-IL-9) (Ab175530) - ELISA
Immobilized Recombinant Human IL-9 Protein (rp147650) at 1.0 μg/mL can bind Enokizumab (anti-IL-9) (Ab175530) with the EC₅₀ of 487.9 ng/mL.

Enokizumab (anti-IL-9) (Ab175530) - SEC
The purity of Enokizumab (anti-IL-9) (Ab175530) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot Number Certificate Type Date Item
ZJ23F1101608 Certificate of Analysis Nov 08, 2023 Ab175530
ZJ23F1101609 Certificate of Analysis Nov 08, 2023 Ab175530

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.